Palmitoyl-carnitine production by blood cells associates with the concentration of circulating acyl-carnitines in healthy overweight women.

[1]  N. Deutz,et al.  Transorgan fluxes in a porcine model reveal a central role for liver in acylcarnitine metabolism. , 2015, American journal of physiology. Endocrinology and metabolism.

[2]  D. Chinkes,et al.  Triglycerides produced in the livers of fasting rabbits are predominantly stored as opposed to secreted into the plasma. , 2015, Metabolism: clinical and experimental.

[3]  R. McPherson,et al.  Acylcarnitines: potential implications for skeletal muscle insulin resistance , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[4]  C. Argmann,et al.  Plasma acylcarnitines inadequately reflect tissue acylcarnitine metabolism. , 2014, Biochimica et biophysica acta.

[5]  B. Wall,et al.  Carnitine metabolism and human nutrition , 2014 .

[6]  Joel Stein,et al.  Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. , 2014, Circulation.

[7]  M. Jensen,et al.  Hyperinsulinemia and skeletal muscle fatty acid trafficking. , 2013, American journal of physiology. Endocrinology and metabolism.

[8]  E. Schleicher,et al.  Production and release of acylcarnitines by primary myotubes reflect the differences in fasting fat oxidation of the donors. , 2013, The Journal of clinical endocrinology and metabolism.

[9]  F. Vaz,et al.  Acylcarnitines , 2012, Diabetes.

[10]  E. Parks,et al.  Postprandial changes in plasma acylcarnitine concentrations as markers of fatty acid flux in overweight and obesity. , 2012, Metabolism: clinical and experimental.

[11]  R. Wolfe,et al.  Measurement of precursor enrichment for calculating intramuscular triglyceride fractional synthetic rate , 2012, Journal of Lipid Research.

[12]  F. Toledo,et al.  Increased Levels of Plasma Acylcarnitines in Obesity and Type 2 Diabetes and Identification of a Marker of Glucolipotoxicity , 2010, Obesity.

[13]  G. Briand,et al.  Deuterated palmitate-driven acylcarnitine formation by whole-blood samples for a rapid diagnostic exploration of mitochondrial fatty acid oxidation disorders. , 2009, Clinica chimica acta; international journal of clinical chemistry.

[14]  C. Hoppel,et al.  Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid beta-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American women. , 2009, The Journal of nutrition.

[15]  M. Febbraio,et al.  Overexpression of Carnitine Palmitoyltransferase-1 in Skeletal Muscle Is Sufficient to Enhance Fatty Acid Oxidation and Improve High-Fat Diet–Induced Insulin Resistance , 2009, Diabetes.

[16]  J. Houmard,et al.  Intramuscular lipid metabolism, insulin action, and obesity , 2009, IUBMB life.

[17]  J. Houmard.  Intramuscular lipid oxidation and obesity. , 2008, American journal of physiology. Regulatory, integrative and comparative physiology.

[18]  R. Wolfe,et al.  Measurement of stable isotopic enrichment and concentration of long-chain fatty acyl-carnitines in tissue by HPLC-MS Published, JLR Papers in Press, November 21, 2005. , 2006, Journal of Lipid Research.

[19]  D. Chinkes,et al.  Isotope Tracers in Metabolic Research: Principles and Practice of Kinetic Analysis , 2004 .

[20]  G. Shulman,et al.  Skeletal muscle lipid metabolism with obesity. , 2003, American journal of physiology. Endocrinology and metabolism.

[21]  W. Saris,et al.  Plasma free Fatty Acid uptake and oxidation are already diminished in subjects at high risk for developing type 2 diabetes. , 2001, Diabetes.

[22]  G. Cooney,et al.  Long-chain acyl-CoA esters as indicators of lipid metabolism and insulin sensitivity in rat and human muscle. , 2000, American journal of physiology. Endocrinology and metabolism.

[23]  C. Greenberg,et al.  A simple screening test for fatty acid oxidation defects using whole-blood palmitate oxidation , 1999, Journal of Inherited Metabolic Disease.

[24]  G. Reaven,et al.  Pathophysiology of insulin resistance in human disease. , 1995, Physiological reviews.

[25]  A. Legrand,et al.  Rapid Diagnosis of Long Chain and Medium Chain Fatty Acid Oxidation Disorders Using Lymphocytes , 1995, Annals of clinical biochemistry.

[26]  O. Ilkayeva,et al.  Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. , 2008, Cell metabolism.

[27]  J. McGarry,et al.  Prolonged inhibition of muscle carnitine palmitoyltransferase-1 promotes intramyocellular lipid accumulation and insulin resistance in rats. , 2001, Diabetes.